Proacipimox
Latest Information Update: 15 Dec 1994
At a glance
- Originator Pharmacia Corporation
- Class Antihyperlipidaemics
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 14 Dec 1994 No-Development-Reported for Hyperlipidaemia in Sweden (Unknown route)